These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15939190)

  • 1. Mechanisms of sarcomagenesis.
    Matushansky I; Maki RG
    Hematol Oncol Clin North Am; 2005 Jun; 19(3):427-49, v. PubMed ID: 15939190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of sarcoma development.
    Helman LJ; Meltzer P
    Nat Rev Cancer; 2003 Sep; 3(9):685-94. PubMed ID: 12951587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous expression of melanoma antigen (hMAGE) mRNA in mesenchymal neoplasia.
    Joyner DE; Damron TA; Aboulafia A; Bokor W; Bastar JD; Randall RL
    Tissue Antigens; 2006 Jul; 68(1):19-27. PubMed ID: 16774536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance of molecular genetics in soft tissue sarcomas.
    Ordóñez JL; Osuna D; García-Domínguez DJ; Amaral AT; Otero-Motta AP; Mackintosh C; Sevillano MV; Barbado MV; Hernández T; de Alava E
    Adv Anat Pathol; 2010 May; 17(3):162-81. PubMed ID: 20418671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNAs in chromosomal translocation-associated solid tumors: learning from sarcomas.
    Dela Cruz F; Matushansky I
    Discov Med; 2011 Oct; 12(65):307-17. PubMed ID: 22031668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET.
    Riggi N; Cironi L; Suvà ML; Stamenkovic I
    J Pathol; 2007 Sep; 213(1):4-20. PubMed ID: 17691072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcomas: genetics, signalling, and cellular origins. Part 2: TET-independent fusion proteins and receptor tyrosine kinase mutations.
    Suvà ML; Cironi L; Riggi N; Stamenkovic I
    J Pathol; 2007 Oct; 213(2):117-30. PubMed ID: 17703479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of genetic testing in soft tissue sarcoma.
    Antonescu CR
    Histopathology; 2006 Jan; 48(1):13-21. PubMed ID: 16359533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling in sarcomas.
    Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Targeted treatment of rare connective tissue tumors and sarcomas].
    Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
    Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology and potential therapeutic targets in soft-tissue sarcoma.
    Todd R; Lunec J
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):939-48. PubMed ID: 18533803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adult human sarcomas. I. Basic science.
    Sinkovics JG
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):31-56. PubMed ID: 17187519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric sarcomas: translating molecular pathogenesis of disease to novel therapeutic possibilities.
    Anderson JL; Denny CT; Tap WD; Federman N
    Pediatr Res; 2012 Aug; 72(2):112-21. PubMed ID: 22546864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression profiling of human sarcomas: insights into sarcoma biology.
    Baird K; Davis S; Antonescu CR; Harper UL; Walker RL; Chen Y; Glatfelter AA; Duray PH; Meltzer PS
    Cancer Res; 2005 Oct; 65(20):9226-35. PubMed ID: 16230383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcoma epidemiology and etiology: potential environmental and genetic factors.
    Lahat G; Lazar A; Lev D
    Surg Clin North Am; 2008 Jun; 88(3):451-81, v. PubMed ID: 18514694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapies for soft-tissue sarcomas.
    Tap WD; Federman N; Eilber FC
    Expert Rev Anticancer Ther; 2007 May; 7(5):725-33. PubMed ID: 17492935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted therapies for sarcomas: new roles for the pathologist.
    Al-Zaid T; Somaiah N; Lazar AJ
    Histopathology; 2014 Jan; 64(1):119-33. PubMed ID: 24117526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using biology to guide the treatment of sarcomas and aggressive connective-tissue tumours.
    Dufresne A; Brahmi M; Karanian M; Blay JY
    Nat Rev Clin Oncol; 2018 Jul; 15(7):443-458. PubMed ID: 29666441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular biology diagnosis of sarcoma].
    Myklebost O
    Tidsskr Nor Laegeforen; 1998 May; 118(14):2188-93. PubMed ID: 9656816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular pathology of sarcomas.
    Powers M; Zhang W; Lopez-Terrada D; Czerniak BA; Lazar AJ
    Cancer Biomark; 2010; 9(1-6):475-91. PubMed ID: 22112491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.